Huntleigh Advisors, Inc. Veracyte, Inc. Transaction History
Huntleigh Advisors, Inc.
- $518 Billion
- Q2 2025
A detailed history of Huntleigh Advisors, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 21,809 shares of VCYT stock, worth $785,124. This represents 0.11% of its overall portfolio holdings.
Number of Shares
21,809
Previous 20,933
4.18%
Holding current value
$785,124
Previous $621 Million
5.02%
% of portfolio
0.11%
Previous 0.15%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
295Shares Held
77.2MCall Options Held
0Put Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA8.1MShares$292 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$281 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$189 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$137 Million0.85% of portfolio
-
Wellington Management Group LLP Boston, MA3.47MShares$125 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.58B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...